177 related articles for article (PubMed ID: 38405104)
21. Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration.
Kataoka K; Itagaki K; Hashiya N; Wakugawa S; Tanaka K; Nakayama M; Yamamoto A; Mukai R; Honjyo J; Maruko I; Kawai M; Miyara Y; Terao N; Wakatsuki Y; Onoe H; Mori R; Koizumi H; Sekiryu T; Iida T; Okada AA;
Graefes Arch Clin Exp Ophthalmol; 2024 Jan; 262(1):43-51. PubMed ID: 37668741
[TBL] [Abstract][Full Text] [Related]
22. Subfoveal Choroidal Thickness in Eyes with Neovascular Age-Related Macular Degeneration Treated with Anti-Vascular Endothelial Growth Factor Agents.
Kanadani TCM; Veloso CE; Nehemy MB
Ophthalmologica; 2018; 240(4):200-207. PubMed ID: 29768266
[TBL] [Abstract][Full Text] [Related]
23. One-year outcomes and safety assessment of faricimab in treatment-naïve patients with neovascular age-related macular degeneration in Japan.
Mukai R; Kataoka K; Tanaka K; Miyara Y; Maruko I; Nakayama M; Watanabe Y; Yamamoto A; Wakatsuki Y; Onoe H; Wakugawa S; Terao N; Hasegawa T; Kawai M; Maruko R; Itagaki K; Honjo J; Okada AA; Mori R; Koizumi H; Iida T; Sekiryu T
Sci Rep; 2024 May; 14(1):11681. PubMed ID: 38778065
[TBL] [Abstract][Full Text] [Related]
24. Real-World Outcomes of a Loading Phase with Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration (n-AMD) and Diabetic Macular Edema (DME).
Giancipoli E; Guglielmi A; Bux AV; Clima GME; Pignatelli F; Boscia F; Viggiano P; Boscia G; Fortunato F; Besozzi G; Niro A; Dore S; Iaculli C
Ophthalmol Ther; 2024 Jun; ():. PubMed ID: 38831127
[TBL] [Abstract][Full Text] [Related]
25. Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Pachychoroid Neovasculopathy.
Cho HJ; Jung SH; Cho S; Han JO; Park S; Kim JW
J Ocul Pharmacol Ther; 2019 Apr; 35(3):174-181. PubMed ID: 30807236
[TBL] [Abstract][Full Text] [Related]
26. Using optical coherence tomography angiography in assessment of the anti-vascular endothelial growth factor effect for pathological vascular tissue in age-related macular degeneration and polypoidal choroidal vasculopathy.
Shen YS; Cheng CK
Eur J Ophthalmol; 2021 May; 31(3):1267-1280. PubMed ID: 32228025
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic effects of faricimab on aflibercept-refractory age-related macular degeneration.
Tamiya R; Hata M; Tanaka A; Tsuchikawa M; Ueda-Arakawa N; Tamura H; Miyata M; Takahashi A; Kido A; Muraoka Y; Miyake M; Ooto S; Tsujikawa A
Sci Rep; 2023 Nov; 13(1):21128. PubMed ID: 38036627
[TBL] [Abstract][Full Text] [Related]
28. Pachychoroid neovasculopathy: a type-1 choroidal neovascularization belonging to the pachychoroid spectrum-pathogenesis, imaging and available treatment options.
Sartini F; Figus M; Casini G; Nardi M; Posarelli C
Int Ophthalmol; 2020 Dec; 40(12):3577-3589. PubMed ID: 32729062
[TBL] [Abstract][Full Text] [Related]
29. Short-term results for brolucizumab in treatment-naïve neovascular age-related macular degeneration: a Japanese multicenter study.
Tanaka K; Koizumi H; Tamashiro T; Itagaki K; Nakayama M; Maruko I; Wakugawa S; Terao N; Onoe H; Wakatsuki Y; Kasai A; Ogasawara M; Shintake H; Sugano Y; Yamamoto A; Kataoka K; Hasegawa T; Izumi T; Kawai M; Maruko R; Sekiryu T; Okada AA; Iida T; Mori R
Jpn J Ophthalmol; 2022 Jul; 66(4):379-385. PubMed ID: 35595951
[TBL] [Abstract][Full Text] [Related]
30. Short-Term Outcomes of Faricimab in Patients with Neovascular Age-Related Macular Degeneration on Prior Anti-VEGF Therapy.
Szigiato A; Mohan N; Talcott KE; Mammo DA; Babiuch AS; Kaiser PK; Ehlers JP; Rachitskaya A; Yuan A; Srivastava SK; Sharma S
Ophthalmol Retina; 2024 Jan; 8(1):10-17. PubMed ID: 37673396
[TBL] [Abstract][Full Text] [Related]
31. Short-term outcomes of intravitreal faricimab for refractory neovascular age-related macular degeneration.
Aljundi W; Munteanu C; Seitz B; Abdin AD
Graefes Arch Clin Exp Ophthalmol; 2024 Apr; ():. PubMed ID: 38607409
[TBL] [Abstract][Full Text] [Related]
32. Difference Between the Incidence of Retinal Fluid Subtypes and Their Association with Visual Outcomes According to the Types of Macular Neovascularization in a Korean Population.
Kim JH; Kim JW; Kim CG
J Ocul Pharmacol Ther; 2022 Apr; 38(3):261-268. PubMed ID: 35119292
[No Abstract] [Full Text] [Related]
33. Prevalence of Polypoidal Choroidal Vasculopathy in Eyes with Neovascular Age-Related Macular Degeneration Resistant to Intravitreal Anti-VEGF Treatment.
Menteş J; Barış ME
Turk J Ophthalmol; 2022 Oct; 52(5):338-341. PubMed ID: 36317811
[TBL] [Abstract][Full Text] [Related]
34. Faricimab Effectively Resolves Intraretinal Fluid and Preserves Vision in Refractory, Recalcitrant, and Nonresponsive Neovascular Age-Related Macular Degeneration.
Cheng AM; Joshi S; Banoub RG; Saddemi J; Chalam KV
Cureus; 2023 Jun; 15(6):e40100. PubMed ID: 37425528
[TBL] [Abstract][Full Text] [Related]
35. Faricimab in neovascular AMD: first report of real-world outcomes in an independent retina clinic.
Stanga PE; Valentín-Bravo FJ; Stanga SEF; Reinstein UI; Pastor-Idoate S; Downes SM
Eye (Lond); 2023 Oct; 37(15):3282-3289. PubMed ID: 36959312
[TBL] [Abstract][Full Text] [Related]
36. Development of Age-Related Macular Degeneration (AMD) in the Fellow Eye of Patients with AMD Treated by Treat-and-Extend Intravitreal Therapy with Aflibercept.
Mimura K; Matsumoto H; Morimoto M; Akiyama H
Ophthalmologica; 2018; 239(2-3):121-127. PubMed ID: 29169154
[TBL] [Abstract][Full Text] [Related]
37. Factors Associated with Success of Switching to Faricimab for Neovascular Age-Related Macular Degeneration Refractory to Intravitreal Aflibercept.
Machida A; Oishi A; Ikeda J; Kurihara J; Yoneda A; Tsuiki E; Hirata Y; Murakami R; Kitaoka T
Life (Basel); 2024 Apr; 14(4):. PubMed ID: 38672747
[TBL] [Abstract][Full Text] [Related]
38. One-year efficacy of "rescue photodynamic therapy" for patients with typical age-related macular degeneration, polypoidal choroidal vasculopathy, and pachychoroid neovasculopathy refractory to anti-vascular endothelial growth factor therapy.
Wada I; Shiose S; Ishikawa K; Kano K; Notomi S; Mori K; Akiyama M; Nakao S; Sonoda KH
Graefes Arch Clin Exp Ophthalmol; 2022 Jun; 260(6):2029-2036. PubMed ID: 35038016
[TBL] [Abstract][Full Text] [Related]
39. Development of Intraretinal Fluid in Neovascular Age-Related Macular Degeneration During Anti-Vascular Endothelial Growth Factor Treatment.
Cho HJ; Yoon W; Yoon J; Na SK; Lee J; Kim J; Kim CG; Kim JW
Am J Ophthalmol; 2022 Feb; 234():6-14. PubMed ID: 34339661
[TBL] [Abstract][Full Text] [Related]
40. Treat-and-Extend Regimen with Aflibercept for Neovascular Age-Related Macular Degeneration: Efficacy and Macular Atrophy Development.
Matsumoto H; Morimoto M; Mimura K; Ito A; Akiyama H
Ophthalmol Retina; 2018 May; 2(5):462-468. PubMed ID: 31047326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
